Fig. 3From: Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trialFlowchart establishment of MTD. DLT, dose limiting toxicity; MTD, maximum tolerated dose; DSMB, Data Safety Monitoring Board; ICI, immune checkpoint inhibitor (ipilimumab + nivolumab);Â M-PHP, percutaneous hepatic perfusion with melphalanBack to article page